Cost-effectiveness of HIV drug resistance testing to inform switching to second line antiretroviral therapy in low income settings

Andrew Phillips, Valentina Cambiano, Fumiyo Nakagawa, Travor Magubu, Alec Miners, Debbie Ford, Deenan Pillay, Andrea De Luca, Jens Lundgren, Paul Revill

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

To guide future need for cheap resistance tests for use in low income settings, we assessed cost-effectiveness of drug resistance testing as part of monitoring of people on first line ART - with switching from first to second line ART being conditional on NNRTI drug resistance mutations being identified.
Original languageEnglish
Pages (from-to)e109148-e109148
JournalPLoS One
Volume9
DOIs
Publication statusPublished - 2014

Keywords

  • HIV
  • cost
  • therapy

Fingerprint

Dive into the research topics of 'Cost-effectiveness of HIV drug resistance testing to inform switching to second line antiretroviral therapy in low income settings'. Together they form a unique fingerprint.

Cite this